Composition
- Active ingredients
- RETEPLASE 18.8MG/VIAL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA103786.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Retavase
- Active substance
- reteplase
- Dosage form
- Vial
- Applicant
- Ekr Therap
- Status
- Prescription
- FDA approval
- 6 May 1998
- Application
- BLA103786-001